Health / Medicine

Mixed results for Bristol/Nektar combination in cancer trial

Mixed results for Bristol/Nektar combination in cancer trial

Published 04/06/2018

Chicago (Reuters) - Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co’s cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led [more…]

FDA wants to shorten new drug monopolies to cut costs

FDA wants to shorten new drug monopolies to cut costs

Published 03/06/2018

CHICAGO (Reuters) - In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times [more…]

Many women with early-stage breast cancer can skip chemotherapy: study

Many women with early-stage breast cancer can skip chemotherapy: study

Published 03/06/2018

CHICAGO (Reuters) - Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their [more…]

Merck’s Keytruda extends lung cancer survival in two trials

Merck’s Keytruda extends lung cancer survival in two trials

Published 03/06/2018

CHICAGO (Reuters) - Merck & Co’s immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous [more…]

America’s poor becoming more destitute under Trump: U.N. expert

America’s poor becoming more destitute under Trump: U.N. expert

Published 02/06/2018

GENEVA (Reuters) - Poverty in the United States is extensive and deepening under the Trump administration whose policies seem aimed at removing the safety net [more…]

FDA chief outlines new ways to speed cancer drug approvals

FDA chief outlines new ways to speed cancer drug approvals

Published 02/06/2018

CHICAGO (Reuters) - The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up [more…]

Roche drugs show limited benefit in lung, breast cancer trials

Roche drugs show limited benefit in lung, breast cancer trials

Published 02/06/2018

CHICAGO (Reuters) - In a disappointment for Roche Holding AG (ROG.S), two of its oncology drugs provided only modest protection from disease progression in lung [more…]

Loxo Oncology posts improved results for newest cancer drug

Loxo Oncology posts improved results for newest cancer drug

Published 02/06/2018

CHICAGO (Reuters) - An experimental cancer drug from Loxo Oncology performed even better in patients with a rare mutation of the RET gene than previously [more…]

Gene sequencing study finds new cancers linked with Lynch syndrome

Gene sequencing study finds new cancers linked with Lynch syndrome

Published 02/06/2018

CHICAGO (Reuters) - Lynch syndrome, a rare hereditary disease typically associated with an increased risk of colorectal and endometrial cancers, appears to be linked with [more…]

Grail blood test shows promise in early detection of lung cancer

Grail blood test shows promise in early detection of lung cancer

Published 02/06/2018

CHICAGO (Reuters) - An experimental blood screening test from Grail Inc showed early promise in detecting early-stage lung cancers based on free-floating DNA released by [more…]